Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Live demo of Genexis TrueTalk[TM] full interoperability with multiple OLTs by RocNet at FiberConnect 2024

Genexis, a leading provider of innovative fiber-to-the-home (FTTH) and broadband solutions for the home, is proud to announce a live demonstration of their advanced Optical Network Terminals (ONTs) at FiberConnect 2024.This demonstration will be hosted by our valued partner, RocNet Supply, at booth 686. Attendees will experience the power of Genexis TrueTalk[TM] in full interoperability with multiple OLT brands integrated into two cutting-edge network technology setups. Demo 1: GPON/XGSPON – ITU Centralized FTTH Technology This demo will feature Genexis' XGS2110 ONT, integrated into a

Repurchase of Truecaller B shares in week 28, 2024

During 22 July 2024 and 26 July 2024 Truecaller AB (publ) (LEI code 549300TEYF1FA5G5GK26) has repurchased in total 260,000 own B shares (ISIN: SE0016787071) as part of the share buyback programme initiated by the board of directors.The share buybacks form part of the share buyback programme announced by Truecaller on 28 May 2024. The share buyback programme will run between 28 May up until the 2025 AGM which will be held in May 2025, and is carried out in accordance “Emittentregelverket”. On the Annual General Meeting 2024 the Board was authorized to buy back B-shares up until the Annual

CORRECTION: Total number of shares less equity shares corrected. Dampskibsselskabet NORDEN A/S – final weekly report on share buy-back

ANNOUNCEMENT NO. 169 – 26 JULY 2024   On 25 April 2024, NORDEN initiated a share buy-back programme in accordance with Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and Commission Delegated Regulation (EU) 2016/1052, (Safe Harbour regulation). The share buy-back programme runs from 26 April 2024 up to and including no later than 1 August 2024. For details, please see announcement no. 96 of 25 April 2024.   Under the share buy-back programme, NORDEN will purchase shares for up to a total of USD 21 million (approximately DKK 145 million).

Wetteri Plc – Managers’ Transactions – PM Ruukki Oy

Wetteri Plc Managers’ Transactions 27 July 2024 at 9.00____________________________________________ Person subject to the notification requirement Name: PM Ruukki Oy Position: Closely associated person (X) Legal person  (1):Person Discharging Managerial Responsibilities In Issuer Name: Markku Kankaala Position: Member of the Board Issuer: Wetteri Oyj LEI: 743700TDB62DGAFROB24 Notification type: INITIAL NOTIFICATION Reference number: 71028/4/4 ____________________________________________ Transaction date: 2024-07-25 Venue: NASDAQ HELSINKI LTD (XHEL)

Lucara Second Quarter 2024 Results to be Released on Friday, August 9, 2024

VANCOUVER, B.C., July 26, 2024 /CNW/ (LUC – TSX, LUC – BSE, LUC – Nasdaq Stockholm)   Lucara Diamond Corp. (“Lucara” or the “Company”) announces that it will be publishing its Second Quarter 2024 Results on Friday, August 9, 2024, after market close in North America.    On behalf of the Board,   William Lamb President and Chief Executive Officer   Follow Lucara Diamond on Facebook , Instagram  and LinkedIn    The

Relais Group Plc: Share Repurchase 26.7.2024

Relais Group Plc  ANNOUNCEMENT  26.7.2024 Relais Group Plc: Share Repurchase 26.7.2024 In the Helsinki Stock Exchange Trade date           26.7.2024Bourse trade         BuyShare                  RELAISAmount             500 SharesAverage price/ share    13,1500 EURTotal cost            6 575,00 EUR Relais Group Plc now holds a total of 38 154 sharesincluding the shares repurchased on 26.7.2024 On behalf of Relais Group Plc Nordea Bank Oyj Janne

DNB Bank ASA – status of share buy-back programme after week 30 2024

On 17 June 2024, DNB Bank ASA (“DNB”) announced that the company has decided to initiate a share buy-back programme comprising up to 1.0 percent of the company’s own shares, which represents a total of 14,925,301 shares. Up to 9,850,699 shares will be purchased on trading venues by 13 September 2024, and a proposal to cancel the shares will be made at the Annual General Meeting in 2025. At the same meeting it will also be proposed to redeem the remaining shares – up to 5,074,602 shares – from the Norwegian Government, represented by the Ministry of Trade, Industry and Fisheries (“NFD”),

Liquefied Gas Cargo Containment Innovations from Jiangnan Shipyard Receive ABS AIPs

(SHANGHAI) ABS awarded approval in principle (AIP) to two new developments from Jiangnan Shipyard: a new insulation system and a modern design for an ultra large ethane carrier (ULEC).   The ULEC design is the first equipped with the next-generation BrilliancE® II Type-B cargo containment system, a modern cryogenic liquefied gas containment system designed to optimize ship performance. The second AIP was awarded for Jiangnan’s patented insulation system, PnFCOMBi, which can be used for type B tank low-temperature containment systems up to -163 degrees Celsius. ABS completed

Calliditas partner STADA receives European Commission decision for full approval of Kinpeygo® for the treatment of IgA Nephropathy

Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) (“Calliditas”) today announced that the European Commission has granted a full marketing authorization for Kinpeygo for the treatment of adults with primary immunoglobulin A nephropathy (IgAN).The European Commission has granted a full marketing authorization of Kinpeygo®. The granting of the full approval results in a significantly broader label for patients with primary IgAN, moving from a urine protein excretion (UPCR) limitation of > 1.5g/g to encompassing the entire study population, defined as UPCR of ≥ 0.8g/g, or

#24-264 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for companies

Stora Enso Oyj: Notification of Change in Holdings according to Chapter 9, Section 10 of the Finnish Securities Markets Act (25 July 2024)

STORA ENSO OYJ STOCK EXCHANGE RELEASE 26 July 2024 at 17:40 EESTStora Enso Oyj received a notification pursuant to chapter 9, section 5 of the Securities Market Act from BlackRock, Inc on 26 July 2024. On 25 July 2024, BlackRock's total holding, including holding through financial instruments, in Stora Enso’s shares increased above the 5 percent threshold. +----------------+--------------+-----------------------------+---------------+|  |% of shares |% of shares and voting rights|Total of both || |and voting |through financial instruments|in % (7.

Ahlstrom announces the closure of its Bousbecque plant in France

AHLSTROM OYJ, PRESS RELEASE, JULY 26, 2024 at 17:30 EEST  In April 2024, Ahlstrom initiated a consultation process with employee representatives on the possibility to divest or close the Bousbecque plant in France and to centralize parchment paper production to its Saint-Séverin plant, also in France, to ensure the long-term future and competitiveness of the parchment paper business.  Despite an active search and in-depth dialogue with local stakeholders, Ahlstrom has been unable to find solutions that would allow the Group or a potential buyer to continue operating the Bousbecque

EQT INFRASTRUCTURE VI, THROUGH OTELLO BIDCO AB, PUBLISHES SUPPLEMENT TO THE OFFER DOCUMENT FOR THE RECOMMENDED PUBLIC OFFER TO THE SHAREHOLDERS OF OX2 AB (PUBL)

This announcement is not an offer, whether directly or indirectly, in Australia, Hong Kong, Japan, New Zealand or South Africa or in any other jurisdiction where such offer pursuant to legislation and regulations in such relevant jurisdiction would be prohibited by applicable law. Shareholders not resident in Sweden who wish to accept the Offer (as defined below) must make inquiries concerning applicable legislation and possible tax consequences. Shareholders should refer to the offer restrictions included in the section titled “Important information” at the end of this announcement and in

Grant of incentive warrants to Employees, CEO and the Board of Directors

The Board of Directors of Cessatech A/S ("Cessatech" or the “Company”) has decided to grant a new incentive warrants to existing and new employees, to the CEO and the Board of Directors. The reason for the new warrant program is to retain and incentivize the employees, the Board of Directors and the CEO by offering a long-term ownership engagement, which will contribute to an alignment of interests between the warrant holders and the shareholders and promote long-term commitment to the Company’s development.Background and final termsOn 26 July 2024 it was decided to grant 250,000 warrants

CS MEDICA A/S Evaluates Pre-IPO Share Distribution for CANNORDIC Stock Spin-off

CS MEDICA Aims to Strengthen Shareholder Bonds with Pre-IPO Share Distribution for CANNORDIC in GermanyCS MEDICA A/S, a pioneering MedTech company specializing in innovative substance-based medical devices containing bioactive CBD, announced on June 10, 2024, its plans to spin off stocks and list its subsidiary CANNORDIC A/S on the German Stock Market (Intention to Float). Today, the company announces its evaluation of the possibility of distributing CANNORDIC shares to existing CS MEDICA shareholders ahead of the planned initial public offering (IPO) in 2024, approved at the

Borr Drilling Limited – Contracting Update

Borr Drilling Limited (NYSE and OSE: “BORR”) is pleased to announce new contract commitments for three of its premium jack-up rigs, the “Arabia I”, the “Gunnlod” and the “Norve”.  These commitments cover a total of 1,779 days and $332 million in contract revenue, including mobilization and demobilization compensation.  The “Arabia I” which had its work scope suspended earlier this year in Saudi Arabia has secured a new long-term contract in Brazil. The contract period is 4 years firm plus a 4 years unpriced option. This contract is expected to commence in Q1 2025 in cooperation with an

CORRECTION: ACQUISITION OF OWN SHARES OF Alexandria Group Oyj

CORRECTION: ACQUISITION OF OWN SHARES OF Alexandria Group OyjALEXANDRIA GROUP OYJ Company Announcement 26.7.2024 at 15:00 EET   Correction: Starting from 19 June 2024, the company announcement of Alexandria Group Oyj (the company) relating to the acquisition of own shares of the company have contained incorrect information on the number of own shares held by the company. The correct numbers have been 152 541 shares lower than the previously announced numbers. The correct numbers of own shares held by the company are as follows:   22,889 shares                   19.06.2024

Should You Water Grass While It’s Sunny? - Expert Advice

Watering the lawn is a fundamental part of keeping your garden green and healthy. But with so many conflicting opinions floating around, it can be confusing to know exactly when to water your grass. A common question many homeowners ask is: should you water your grass while it's sunny?   [A sprinkler spraying water on grass Description automatically generated]   Here, gardening expert Fiona Jenkins at MyJobQuote.co.uk  delves into the world of lawn care and explores the pros and cons of watering during sunny spells, along with expert advice to

DOF GROUP ASA - Extraordinary General Meeting

Austevoll, 26 July 2024: Reference is made to the stock exchange announcement made by DOF Group ASA (the "Company", OSE ticker code "DOFG") on 2 July 2024 regarding an agreement to acquire Maersk Supply Service A/S (the "Transaction"), and on 5 July 2024 regarding an extraordinary general meeting to be held on 26 July 2024 (the "EGM"). The EGM was held today as a digital meeting with online participation. All proposals on the agenda were adopted, cf. the notice of the EGM that was published on 5 July 2024. The EGM elected two new board members: Erik Bergöö as the vice chairperson of the

Eisai will seek re-examination of CHMP opinion för lecanemab

Stockholm, Sweden July 26, 2024 – BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that they will request re-examination of the Committee for Medicinal Products for Human Use (CHMP’s) negative opinion posted today on the Marketing Authorization Approval (MAA) for lecanemab as treatment for Alzheimer’s disease in the EU.“We are surprised and very disappointed by the CHMP’s opinion posted today. Foremost  the negative opinion adopted by the CHMP is sad for all patients, caregivers and healthcare professionals in the EU who will now have to wait longer for a

CHMP has adopted a negative opinion on lecanemab for the EU

Stockholm, Sweden July 26, 2024 – The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has today communicated that it has adopted a negative opinion on BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai’s Marketing Authorization Approval (MAA) for lecanemab as treatment for Alzheimer’s disease. BioArctic is currently consulting Eisai regarding forthcoming actions. A further update will be communicated later todayLecanemab is already approved in the United States, Japan, China, South Korea, Hong Kong, and Israel and is being marketed in

There are no items matching the current filter
There are no more items matching the current filter
Back to top